Sam Thiagalingam - Concepedia

Author

Sam Thiagalingam

Boston University ORCID

Also Known As

Mozaffari, Sahar, S Thiagalingam, S. Thiagalingam, SAM THIAGALINGAM, Sam Thiagalingam, Sambasivamoorthy Thiagalingam

172

Publications

11K

Citations

H-Index

Concepts

All Affiliations

Boston University Johns Hopkins University Harvard University Johns Hopkins Medicine Beth Israel Deaconess Medical Center

About

Sam Thiagalingam is an author at Boston University specializing in medicine, tumor biology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	27	6.9K
2	Natural Sciences	4	4	432
3	Engineering	2	2	342
4	Health Sciences	2	2	479
5	Social Sciences	1	1	458

Sam Thiagalingam

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam, Nature Tumor BiologyOncogenic AgentMedicineCancer BiologyTumor Suppressor	1993	1.5K
Is a p53-Regulated Inhibitor of G2/M Progression Heiko Hermeking, Christoph Lengauer, Kornélia Polyák, Molecular Cell	1997	1.2K
Oncogenic forms of p53 inhibit p53-regulated gene expression S E Kern, JA Pietenpol, Sam Thiagalingam, Science Tumor BiologyOncogenic AgentMedicineTumor Suppressor P53Oncogenic Forms	1992	918
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers Sam Thiagalingam, Christoph Lengauer, Frederick S. Leach, Nature Genetics Tumor BiologyChromatinColorectal CancersMedicineGenetics	1996	609
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hamid M. Abdolmaleky, Kuang‐Hung Cheng, Stephen V. Faraone, Human Molecular Genetics Major Risk FactorEpigenetic ChangeGeneticsMental IllnessesGenetic Epidemiology	2006	458
Sequence-specific transcriptional activation is essential for growth suppression by p53. Jennifer A. Pietenpol, Takashi Tokino, Sam Thiagalingam, Proceedings of the National Academy of Sciences Cell ProliferationCancer BiologyTumor BiologyTranscriptional RegulationCell Regulation	1994	408
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. William M. Grady, Lois L. Myeroff, Sandra E. Swinler, PubMed Tumor BiologyOncologyMedicineMicrosatellite InstabilityColorectal Cancer	1999	392
Hypermethylation of the reelin (<i>RELN</i>) promoter in the brain of schizophrenic patients: A preliminary report Hamid M. Abdolmaleky, Kuang‐Hung Cheng, Andrea Russo, American Journal of Medical Genetics Part B Neuropsychiatric Genetics	2005	388
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression Scott E. Kern, Jennifer A. Pietenpol, Sam Thiagalingam, Science Tumor BiologyOncogenic AgentMedicineTumor Suppressor P53Oncogenic Forms	1992	343
Mad-related genes in the human Gregory J. Riggins, Sam Thiagalingam, Ester Rozenblum, Nature Genetics Mad-related GenesGenetic DisorderGeneticsMolecular GeneticsMedicine	1996	310

Page 1